As part of a joint exhibition by Nutshell, Manteia Medical (China), and Cas Ion (China), advanced solutions in radiation oncology were presented, aimed at developing and localising proton-therapy technologies within the Russian Federation.

Manteia Medical showcased its artificial-intelligence platform for automated contouring and radiotherapy planning.

Cas Ion, a leading Chinese manufacturer of proton-therapy complexes, presented its approach to designing and integrating next-generation accelerator systems.

Nutshell LLC acted as a technology integrator, delivering adaptation, service support, and implementation of these solutions across Russia and the EAEU.

During the congress, meetings were held with representatives of the FMBA of Russia and regional oncology centres, focusing on localisation of proton-complex components, development of service infrastructure, and training opportunities for Russian engineers at Cas Ion and Manteia facilities.

Nutshell’s participation in RORR-2025 underscored the company’s growing role as a bridge between international developers and the Russian radiation-oncology ecosystem.